{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:33:45Z","timestamp":1784252025232,"version":"3.55.0"},"reference-count":201,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02682-1","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T18:45:38Z","timestamp":1740768338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A review of the carcinogenic potential of human papillomavirus (HPV) in urological cancers"],"prefix":"10.1186","volume":"22","author":[{"given":"Ehsan","family":"Zolfi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhood","family":"Khaleghi Mehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoo","family":"Emtiazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"2682_CR1","doi-asserted-by":"crossref","unstructured":"Konecki T, Juszczak A, Cichocki M. Can diet prevent urological cancers?? An update on carotenoids as chemopreventive agents. Nutrients, 2022. 14(7).","DOI":"10.3390\/nu14071367"},{"issue":"1","key":"2682_CR2","doi-asserted-by":"publisher","first-page":"100124","DOI":"10.1016\/j.advnut.2023.09.012","volume":"15","author":"Y-n Dai","year":"2024","unstructured":"Dai Y-n, et al. The association between dietary inflammatory potential and urologic cancers: a meta-analysis. Adv Nutr. 2024;15(1):100124.","journal-title":"Adv Nutr"},{"issue":"6","key":"2682_CR3","first-page":"1521","volume":"30","author":"C Carrillo-Infante","year":"2007","unstructured":"Carrillo-Infante C, et al. Viral infections as a cause of cancer. Int J Oncol. 2007;30(6):1521\u20138.","journal-title":"Int J Oncol"},{"key":"2682_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ijsu.2018.02.050","volume":"52","author":"SH Abidi","year":"2018","unstructured":"Abidi SH, et al. Viral etiology of prostate cancer: genetic alterations and immune response. A literature review. Int J Surg. 2018;52:136\u201340.","journal-title":"Int J Surg"},{"key":"2682_CR5","doi-asserted-by":"crossref","unstructured":"Sarier M. Association between human papillomavirus and urological cancers: an update. Intech Open; 2021.","DOI":"10.5772\/intechopen.101508"},{"key":"2682_CR6","doi-asserted-by":"publisher","first-page":"155574","DOI":"10.1016\/j.prp.2024.155574","volume":"263","author":"D Aden","year":"2024","unstructured":"Aden D, et al. Navigating the landscape of HPV-associated cancers: from epidemiology to prevention. Pathology-Research Pract. 2024;263:155574.","journal-title":"Pathology-Research Pract"},{"key":"2682_CR7","doi-asserted-by":"crossref","unstructured":"Lehmann V, Laan ET, den Oudsten BL. Sexual health-related care needs among young adult cancer patients and survivors: a systematic literature review. J Cancer Surviv. 2022;16:913\u2013924.","DOI":"10.1007\/s11764-021-01084-w"},{"key":"2682_CR8","volume-title":"Urological infections","author":"G Bonkat","year":"2018","unstructured":"Bonkat G, et al. Urological infections. Arnhem: European Association of Urology; 2018."},{"issue":"3","key":"2682_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/0391560319846012","volume":"86","author":"S Emilio","year":"2019","unstructured":"Emilio S, et al. Lifestyle in urology: Cancer. Urol J. 2019;86(3):105\u201314.","journal-title":"Urol J"},{"key":"2682_CR10","doi-asserted-by":"crossref","unstructured":"Hansel DE. A 25 year perspective on advances in the pathologic assessment and diagnosis of urologic cancers. Urologic oncology: seminars and original investigations. 2021;39(9):582\u2013594.","DOI":"10.1016\/j.urolonc.2021.05.016"},{"issue":"2","key":"2682_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/infdis\/jir248","volume":"204","author":"N Li","year":"2011","unstructured":"Li N, et al. Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis. 2011;204(2):217\u201323.","journal-title":"J Infect Dis"},{"issue":"4","key":"2682_CR12","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.brachy.2013.06.001","volume":"13","author":"B Delaunay","year":"2014","unstructured":"Delaunay B, et al. Brachytherapy for penile cancer: efficacy and impact on sexual function. Brachytherapy. 2014;13(4):380\u20137.","journal-title":"Brachytherapy"},{"issue":"5","key":"2682_CR13","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1111\/ajco.13124","volume":"15","author":"M Moghoofei","year":"2019","unstructured":"Moghoofei M, et al. Association between human papillomavirus infection and prostate cancer: A global systematic review and meta-analysis. Asia\u2010Pacific J Clin Oncol. 2019;15(5):e59\u201367.","journal-title":"Asia\u2010Pacific J Clin Oncol"},{"issue":"1","key":"2682_CR14","doi-asserted-by":"publisher","first-page":"16597","DOI":"10.1038\/s41598-023-43767-7","volume":"13","author":"IA Tsydenova","year":"2023","unstructured":"Tsydenova IA, et al. Human papillomavirus and prostate cancer: systematic review and meta-analysis. Sci Rep. 2023;13(1):16597.","journal-title":"Sci Rep"},{"issue":"3","key":"2682_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/bju.16224","volume":"133","author":"J Huang","year":"2024","unstructured":"Huang J, et al. Incidence, risk factors, and Temporal trends of penile cancer: a global population-based study. BJU Int. 2024;133(3):314\u201323.","journal-title":"BJU Int"},{"issue":"7","key":"2682_CR16","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3390\/diagnostics12071759","volume":"12","author":"N Muresu","year":"2022","unstructured":"Muresu N, et al. Prevalence of human papilloma virus infection in bladder cancer: a systematic review. Diagnostics. 2022;12(7):1759.","journal-title":"Diagnostics"},{"issue":"61","key":"2682_CR17","doi-asserted-by":"publisher","first-page":"104654","DOI":"10.18632\/oncotarget.20992","volume":"8","author":"M Boccellino","year":"2017","unstructured":"Boccellino M, et al. Testicular cancer from diagnosis to epigenetic factors. Oncotarget. 2017;8(61):104654.","journal-title":"Oncotarget"},{"issue":"1","key":"2682_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41572-018-0029-0","volume":"4","author":"L Cheng","year":"2018","unstructured":"Cheng L, et al. Testicular cancer. Nat Reviews Disease Primers. 2018;4(1):29.","journal-title":"Nat Reviews Disease Primers"},{"issue":"3","key":"2682_CR19","doi-asserted-by":"publisher","first-page":"e15036","DOI":"10.1371\/journal.pone.0015036","volume":"6","author":"C Foresta","year":"2011","unstructured":"Foresta C, et al. Mechanism of human papillomavirus binding to human spermatozoa and fertilizing ability of infected spermatozoa. PLoS ONE. 2011;6(3):e15036.","journal-title":"PLoS ONE"},{"key":"2682_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fendo.2019.00355","volume":"10","author":"A Garolla","year":"2019","unstructured":"Garolla A, et al. Role of viral infections in testicular cancer etiology: evidence from a systematic review and meta-analysis. Front Endocrinol. 2019;10:355.","journal-title":"Front Endocrinol"},{"key":"2682_CR21","doi-asserted-by":"publisher","first-page":"175883592211272","DOI":"10.1177\/17588359221127254","volume":"14","author":"J Chadha","year":"2022","unstructured":"Chadha J, Chahoud J, Spiess PE. An update on treatment of penile cancer. Therapeutic Adv Med Oncol. 2022;14:17588359221127254.","journal-title":"Therapeutic Adv Med Oncol"},{"issue":"6","key":"2682_CR22","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s00345-023-04425-9","volume":"41","author":"S Xia","year":"2023","unstructured":"Xia S, Li S, Li H. HPV-infection status and urinary incontinence: a population-based analysis of the NHANES 2005\u20132016. World J Urol. 2023;41(6):1597\u2013603.","journal-title":"World J Urol"},{"key":"2682_CR23","doi-asserted-by":"publisher","first-page":"1423874","DOI":"10.3389\/fonc.2024.1423874","volume":"14","author":"S Zhu","year":"2024","unstructured":"Zhu S, et al. Case report: A case report of co-morbidity of cervical intraepithelial neoplasia III and urethral cancer associated with HPV16. Front Oncol. 2024;14:1423874.","journal-title":"Front Oncol"},{"issue":"4","key":"2682_CR24","doi-asserted-by":"publisher","first-page":"e34070","DOI":"10.2196\/34070","volume":"8","author":"H Shin","year":"2022","unstructured":"Shin H, et al. Factors affecting human papillomavirus vaccination in men: systematic review. JMIR Public Health Surveillance. 2022;8(4):e34070.","journal-title":"JMIR Public Health Surveillance"},{"issue":"50","key":"2682_CR25","doi-asserted-by":"publisher","first-page":"8352","DOI":"10.1016\/j.vaccine.2007.09.027","volume":"25","author":"G La Torre","year":"2007","unstructured":"La Torre G, et al. HPV vaccine efficacy in preventing persistent cervical HPV infection: a systematic review and meta-analysis. Vaccine. 2007;25(50):8352\u20138.","journal-title":"Vaccine"},{"key":"2682_CR26","doi-asserted-by":"publisher","first-page":"1077651","DOI":"10.3389\/fcimb.2022.1077651","volume":"12","author":"K Zou","year":"2022","unstructured":"Zou K, Huang Y, Li Z. Prevention and treatment of human papillomavirus in men benefits both men and women. Front Cell Infect Microbiol. 2022;12:1077651.","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"2682_CR27","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2217\/fon.10.150","volume":"6","author":"J Berkhof","year":"2010","unstructured":"Berkhof J, Bogaards JA. Vaccination against human papillomavirus types 16 and 18: the impact on cervical cancer. Future Oncol. 2010;6(12):1817\u201321.","journal-title":"Future Oncol"},{"issue":"8","key":"2682_CR28","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/v13081668","volume":"13","author":"I Markovi\u0107","year":"2021","unstructured":"Markovi\u0107 I, et al. Molecular characterization of human papillomavirus type 159 (HPV159). Viruses. 2021;13(8):1668.","journal-title":"Viruses"},{"issue":"14","key":"2682_CR29","doi-asserted-by":"publisher","first-page":"7616","DOI":"10.3390\/ijms25147616","volume":"25","author":"B Mlynarczyk-Bonikowska","year":"2024","unstructured":"Mlynarczyk-Bonikowska B, Rudnicka L, Infections\u2014Classification HPV. Pathogenesis, and potential new therapies. Int J Mol Sci. 2024;25(14):7616.","journal-title":"Int J Mol Sci"},{"key":"2682_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12881-020-01156-1","volume":"21","author":"SN Adebamowo","year":"2020","unstructured":"Adebamowo SN, et al. Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection. BMC Med Genet. 2020;21:1\u201310.","journal-title":"BMC Med Genet"},{"key":"2682_CR31","doi-asserted-by":"publisher","first-page":"1437309","DOI":"10.3389\/fpubh.2024.1437309","volume":"12","author":"W Borena","year":"2024","unstructured":"Borena W, et al. Disproportionate preponderance of HPV genotypes associated with anogenital warts among HIV-positive MSM. Front Public Health. 2024;12:1437309.","journal-title":"Front Public Health"},{"issue":"8","key":"2682_CR32","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.cmi.2019.12.010","volume":"26","author":"L-H Wei","year":"2020","unstructured":"Wei L-H, et al. Age distribution of human papillomavirus infection and neutralizing antibodies in healthy Chinese women aged 18\u201345 years enrolled in a clinical trial. Clin Microbiol Infect. 2020;26(8):1069\u201375.","journal-title":"Clin Microbiol Infect"},{"key":"2682_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.meegid.2013.11.002","volume":"21","author":"IN Mammas","year":"2014","unstructured":"Mammas IN, Spandidos DA, Sourvinos G. Genomic diversity of human papillomaviruses (HPV) and clinical implications: an overview in adulthood and childhood. Infect Genet Evol. 2014;21:220\u20136.","journal-title":"Infect Genet Evol"},{"issue":"23","key":"2682_CR34","doi-asserted-by":"publisher","first-page":"15022","DOI":"10.3390\/ijms232315022","volume":"23","author":"L Giannella","year":"2022","unstructured":"Giannella L, et al. HPV-negative adenocarcinomas of the uterine cervix: from molecular characterization to clinical implications. Int J Mol Sci. 2022;23(23):15022.","journal-title":"Int J Mol Sci"},{"key":"2682_CR35","unstructured":"Afshar ZM et al. Clinical and Public Health Considerations for HPV Infection in Men: A Narrative Review. 2024."},{"issue":"3","key":"2682_CR36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/infdis\/jiab390","volume":"225","author":"RL Winer","year":"2022","unstructured":"Winer RL, et al. Effectiveness of human papillomavirus (HPV) vaccination against penile HPV infection in men who have sex with men and transgender women. J Infect Dis. 2022;225(3):422\u201330.","journal-title":"J Infect Dis"},{"key":"2682_CR37","doi-asserted-by":"crossref","unstructured":"Lee S-J et al. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research. J Gynecologic Oncol, 2016. 27(5).","DOI":"10.3802\/jgo.2016.27.e51"},{"issue":"26","key":"2682_CR38","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.2174\/0929867321666140414101528","volume":"21","author":"J Wu","year":"2014","unstructured":"Wu J, et al. Four major factors regulate phosphatidylinositol 3-kinase signaling pathway in cancers induced by infection of human papillomaviruses. Curr Med Chem. 2014;21(26):3057\u201369.","journal-title":"Curr Med Chem"},{"key":"2682_CR39","doi-asserted-by":"crossref","unstructured":"Mar\u00e9chal A, Zou L. DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol, 2013. 5(9).","DOI":"10.1101\/cshperspect.a012716"},{"key":"2682_CR40","doi-asserted-by":"publisher","first-page":"110266","DOI":"10.1016\/j.virol.2024.110266","volume":"600","author":"T Kono","year":"2024","unstructured":"Kono T, Ozawa H, Laimins L. The roles of DNA damage repair and innate immune surveillance pathways in HPV pathogenesis. Virology. 2024;600:110266.","journal-title":"Virology"},{"issue":"4","key":"2682_CR41","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3892\/mmr.2014.1931","volume":"9","author":"R Tang","year":"2014","unstructured":"Tang R, et al. A correlation analysis of miRNA\u201334a and its predicted target genes in leukemia. Mol Med Rep. 2014;9(4):1283\u20138.","journal-title":"Mol Med Rep"},{"key":"2682_CR42","doi-asserted-by":"publisher","first-page":"115982","DOI":"10.1016\/j.biopha.2023.115982","volume":"170","author":"B Tan","year":"2024","unstructured":"Tan B, et al. Inhibitory actions of Oxyresveratrol on the PI3K\/AKT signaling cascade in cervical cancer cells. Biomed Pharmacother. 2024;170:115982.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2682_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11255-019-02302-2","volume":"52","author":"M Sarier","year":"2020","unstructured":"Sarier M, et al. HPV infection in urology practice. Int Urol Nephrol. 2020;52(1):1\u20138.","journal-title":"Int Urol Nephrol"},{"issue":"13","key":"2682_CR44","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.3390\/cancers14133038","volume":"14","author":"GV Vieira","year":"2022","unstructured":"Vieira GV, et al. Proteases and HPV-induced carcinogenesis. Cancers. 2022;14(13):3038.","journal-title":"Cancers"},{"key":"2682_CR45","doi-asserted-by":"crossref","unstructured":"Hazazi A et al. Signaling pathways in HPV-Induced cervical cancer: exploring the therapeutic promise of RNA modulation. Pathology-Research Pract, 2024: p. 155612. Volume 263","DOI":"10.1016\/j.prp.2024.155612"},{"key":"2682_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12943-015-0361-x","volume":"14","author":"L Zhang","year":"2015","unstructured":"Zhang L, et al. The role of the PI3K\/Akt\/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses. Mol Cancer. 2015;14:87.","journal-title":"Mol Cancer"},{"issue":"8","key":"2682_CR47","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.3390\/v7082842","volume":"7","author":"JO Bello","year":"2015","unstructured":"Bello JO, et al. Regulation of the Wnt\/\u03b2-Catenin signaling pathway by human papillomavirus E6 and E7 oncoproteins. Viruses. 2015;7(8):4734\u201355.","journal-title":"Viruses"},{"key":"2682_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-3-030-55031-8_8","volume":"1287","author":"T Das","year":"2021","unstructured":"Das T, Zhong R, Spiotto MT. Notch signaling and human Papillomavirus-Associated oral tumorigenesis. Adv Exp Med Biol. 2021;1287:105\u201322.","journal-title":"Adv Exp Med Biol"},{"key":"2682_CR49","doi-asserted-by":"publisher","first-page":"633794","DOI":"10.3389\/fonc.2021.633794","volume":"11","author":"J Qiu","year":"2021","unstructured":"Qiu J, et al. Blocking of EGFR signaling is a latent strategy for the improvement of prognosis of HPV-induced cancer. Front Oncol. 2021;11:633794.","journal-title":"Front Oncol"},{"issue":"12","key":"2682_CR50","doi-asserted-by":"publisher","first-page":"8051","DOI":"10.1128\/jvi.69.12.8051-8056.1995","volume":"69","author":"Z Gu","year":"1995","unstructured":"Gu Z, Matlashewski G. Effect of human papillomavirus type 16 oncogenes on MAP kinase activity. J Virol. 1995;69(12):8051\u20136.","journal-title":"J Virol"},{"issue":"1","key":"2682_CR51","doi-asserted-by":"publisher","first-page":"e1009216","DOI":"10.1371\/journal.ppat.1009216","volume":"17","author":"AJ Luna","year":"2021","unstructured":"Luna AJ, et al. MEK\/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors. PLoS Pathog. 2021;17(1):e1009216.","journal-title":"PLoS Pathog"},{"issue":"18","key":"2682_CR52","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1158\/0008-5472.CAN-16-2055","volume":"76","author":"WS El-Deiry","year":"2016","unstructured":"El-Deiry WS. p21 (WAF1) mediates cell-cycle Inhibition, relevant to cancer suppression and therapy. Cancer Res. 2016;76(18):5189\u201391.","journal-title":"Cancer Res"},{"issue":"3","key":"2682_CR53","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ijrobp.2020.02.031","volume":"107","author":"Y Hasan","year":"2020","unstructured":"Hasan Y, et al. A phase 1 trial assessing the safety and tolerability of a therapeutic DNA vaccination against HPV16 and HPV18 E6\/E7 oncogenes after chemoradiation for cervical cancer. Int J Radiation Oncology* Biology* Phys. 2020;107(3):487\u201398.","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"key":"2682_CR54","doi-asserted-by":"crossref","unstructured":"Templeton CW, Laimins LA. p53-dependent R-loop formation and HPV pathogenesis. Proceedings of the National Academy of Sciences. 2023;120(35):e2305907120.","DOI":"10.1073\/pnas.2305907120"},{"key":"2682_CR55","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/rmv.1824","volume":"25","author":"SJ McKee","year":"2015","unstructured":"McKee SJ, Bergot AS, Leggatt GR. Recent progress in vaccination against human papillomavirus-mediated cervical cancer. Rev Med Virol. 2015;25:54\u201371.","journal-title":"Rev Med Virol"},{"issue":"9","key":"2682_CR56","doi-asserted-by":"publisher","first-page":"e29088","DOI":"10.1002\/jmv.29088","volume":"95","author":"X Yao","year":"2023","unstructured":"Yao X, et al. Role of human papillomavirus and associated viruses in bladder cancer: an updated review. J Med Virol. 2023;95(9):e29088.","journal-title":"J Med Virol"},{"issue":"9","key":"2682_CR57","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3390\/v12090977","volume":"12","author":"EL Morgan","year":"2020","unstructured":"Morgan EL, Macdonald A. Manipulation of JAK\/STAT signalling by high-risk HPVs: potential therapeutic targets for HPV-associated malignancies. Viruses. 2020;12(9):977.","journal-title":"Viruses"},{"issue":"23","key":"2682_CR58","doi-asserted-by":"publisher","first-page":"6104","DOI":"10.3390\/cancers13236104","volume":"13","author":"K-B Huang","year":"2021","unstructured":"Huang K-B, et al. Genome-wide profiling reveals HPV integration pattern and activated carcinogenic pathways in penile squamous cell carcinoma. Cancers. 2021;13(23):6104.","journal-title":"Cancers"},{"issue":"4","key":"2682_CR59","doi-asserted-by":"publisher","first-page":"864","DOI":"10.20892\/j.issn.2095-3941.2020.0370","volume":"17","author":"KA Szymonowicz","year":"2020","unstructured":"Szymonowicz KA, Chen J. Biological and clinical aspects of HPV-related cancers. Cancer Biology Med. 2020;17(4):864.","journal-title":"Cancer Biology Med"},{"key":"2682_CR60","doi-asserted-by":"crossref","unstructured":"Rezaei S et al. PI3K\/Akt signaling in urological cancers: tumorigenesis function, therapeutic potential, and therapy response regulation. Eur J Pharmacol, 2023: p. 175909.Volume 955","DOI":"10.1016\/j.ejphar.2023.175909"},{"issue":"1","key":"2682_CR61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11033-023-08931-2","volume":"51","author":"S Lin","year":"2024","unstructured":"Lin S, et al. The role of HIF in angiogenesis, lymphangiogenesis, and tumor microenvironment in urological cancers. Mol Biol Rep. 2024;51(1):14.","journal-title":"Mol Biol Rep"},{"issue":"22","key":"2682_CR62","doi-asserted-by":"publisher","first-page":"6718","DOI":"10.3390\/jcm13226718","volume":"13","author":"TA Balan","year":"2024","unstructured":"Balan TA, et al. Pregnancy-Related precancerous cervical lesions: pathogenesis, diagnosis, evolution, and impact upon gestation and fertility. J Clin Med. 2024;13(22):6718.","journal-title":"J Clin Med"},{"key":"2682_CR63","doi-asserted-by":"publisher","first-page":"1112513","DOI":"10.3389\/fimmu.2023.1112513","volume":"14","author":"RV Hewavisenti","year":"2023","unstructured":"Hewavisenti RV, et al. Human papillomavirus in the setting of immunodeficiency: pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk. Front Immunol. 2023;14:1112513.","journal-title":"Front Immunol"},{"issue":"11","key":"2682_CR64","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.3390\/v5112624","volume":"5","author":"A Amador-Molina","year":"2013","unstructured":"Amador-Molina A, et al. Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response. Viruses. 2013;5(11):2624\u201342.","journal-title":"Viruses"},{"issue":"6","key":"2682_CR65","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10156-012-0485-5","volume":"18","author":"T Sasagawa","year":"2012","unstructured":"Sasagawa T, Takagi H, Makinoda S. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer. J Infect Chemother. 2012;18(6):807\u201315.","journal-title":"J Infect Chemother"},{"issue":"6","key":"2682_CR66","doi-asserted-by":"publisher","first-page":"e29685","DOI":"10.1002\/jmv.29685","volume":"96","author":"I Lo Cigno","year":"2024","unstructured":"Lo Cigno I, et al. High-risk HPV oncoproteins E6 and E7 and their interplay with the innate immune response: Uncovering mechanisms of immune evasion and therapeutic prospects. J Med Virol. 2024;96(6):e29685.","journal-title":"J Med Virol"},{"key":"2682_CR67","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.coviro.2021.09.010","volume":"51","author":"M Stanley","year":"2021","unstructured":"Stanley M. Host defence and persistent human papillomavirus infection. Curr Opin Virol. 2021;51:106\u201310.","journal-title":"Curr Opin Virol"},{"issue":"7","key":"2682_CR68","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1158\/0008-5472.CAN-09-4299","volume":"70","author":"PJ de Vos","year":"2010","unstructured":"de Vos PJ, et al. An unexpectedly large polyclonal repertoire of HPV-specific T cells is poised for action in patients with cervical cancer. Cancer Res. 2010;70(7):2707\u201317.","journal-title":"Cancer Res"},{"issue":"8","key":"2682_CR69","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1158\/2159-8290.CD-20-1760","volume":"11","author":"AA Shamseddine","year":"2021","unstructured":"Shamseddine AA, et al. Tumor immunity and immunotherapy for HPV-related cancers. Cancer Discov. 2021;11(8):1896\u2013912.","journal-title":"Cancer Discov"},{"key":"2682_CR70","doi-asserted-by":"publisher","first-page":"103435","DOI":"10.1016\/j.jri.2021.103435","volume":"148","author":"S Dogan","year":"2021","unstructured":"Dogan S, Terzioglu E, Ucar S. Innate immune response against HPV: possible crosstalking with endocervical \u0393\u03b4 T cells. J Reprod Immunol. 2021;148:103435.","journal-title":"J Reprod Immunol"},{"issue":"2","key":"2682_CR71","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/ijc.31027","volume":"142","author":"A Steinbach","year":"2018","unstructured":"Steinbach A, Riemer AB. Immune evasion mechanisms of human papillomavirus: an update. Int J Cancer. 2018;142(2):224\u20139.","journal-title":"Int J Cancer"},{"issue":"2","key":"2682_CR72","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1128\/CMR.05028-11","volume":"25","author":"MA Stanley","year":"2012","unstructured":"Stanley MA. Epithelial cell responses to infection with human papillomavirus. Clin Microbiol Rev. 2012;25(2):215\u201322.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"2682_CR73","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1473-3099(09)70108-2","volume":"9","author":"MH Einstein","year":"2009","unstructured":"Einstein MH, et al. Clinician\u2019s guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect Dis. 2009;9(6):347\u201356.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"2682_CR74","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/v9090254","volume":"9","author":"S Smola","year":"2017","unstructured":"Smola S. Immunopathogenesis of HPV-associated cancers and prospects for immunotherapy. Viruses. 2017;9(9):254.","journal-title":"Viruses"},{"issue":"12","key":"2682_CR75","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3390\/pathogens12121380","volume":"12","author":"M Jain","year":"2023","unstructured":"Jain M, et al. Epidemiology, molecular pathogenesis, immuno-pathogenesis, immune escape mechanisms and vaccine evaluation for HPV-associated carcinogenesis. Pathogens. 2023;12(12):1380.","journal-title":"Pathogens"},{"issue":"1","key":"2682_CR76","doi-asserted-by":"publisher","first-page":"040470","DOI":"10.1155\/IDOG\/2006\/40470","volume":"2006","author":"KA Ault","year":"2006","unstructured":"Ault KA. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect Dis Obstet Gynecol. 2006;2006(1):040470.","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"3","key":"2682_CR77","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1067\/mob.2003.164","volume":"188","author":"C Mao","year":"2003","unstructured":"Mao C, et al. Clinical findings among young women with genital human papillomavirus infection. Am J Obstet Gynecol. 2003;188(3):677\u201384.","journal-title":"Am J Obstet Gynecol"},{"key":"2682_CR78","doi-asserted-by":"publisher","first-page":"1200466","DOI":"10.3389\/fcell.2023.1200466","volume":"11","author":"D Xie","year":"2023","unstructured":"Xie D, et al. The mechanism and clinical application of DNA damage repair inhibitors combined with immune checkpoint inhibitors in the treatment of urologic cancer. Front Cell Dev Biology. 2023;11:1200466.","journal-title":"Front Cell Dev Biology"},{"issue":"18","key":"2682_CR79","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.3390\/nu15184086","volume":"15","author":"Z Yin","year":"2023","unstructured":"Yin Z, et al. A large genetic causal analysis of the gut microbiota and urological cancers: a bidirectional Mendelian randomization study. Nutrients. 2023;15(18):4086.","journal-title":"Nutrients"},{"issue":"10","key":"2682_CR80","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.3390\/jcm9103195","volume":"9","author":"P Kryst","year":"2020","unstructured":"Kryst P, et al. Epstein-barr virus and human adenovirus viremia in renal tumors is associated with histological features of malignancy. J Clin Med. 2020;9(10):3195.","journal-title":"J Clin Med"},{"issue":"2","key":"2682_CR81","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4149\/neo_2023_220703N681","volume":"70","author":"J Hrb\u00e1\u010dek","year":"2023","unstructured":"Hrb\u00e1\u010dek J, et al. Urinary shedding of common DNA viruses and their possible association with bladder cancer: A qPCR-based study. Neoplasma. 2023;70(2):311\u20138.","journal-title":"Neoplasma"},{"key":"2682_CR82","doi-asserted-by":"crossref","unstructured":"Motlaghzadeh S et al. Association of viral infection with bladder cancer: A systematic review and Meta-analysis. Pathology-Research Pract, 2024: p. 155633.Volume 264","DOI":"10.1016\/j.prp.2024.155633"},{"key":"2682_CR83","doi-asserted-by":"crossref","unstructured":"Mikhaleva L et al. Herpes viruses and human papillomavirus in prostate cancer: first results. Urologiia. 2023(6):95\u2013101.","DOI":"10.18565\/urology.2023.6.95-101"},{"issue":"4","key":"2682_CR84","doi-asserted-by":"publisher","first-page":"379","DOI":"10.30699\/ijmm.17.4.379","volume":"17","author":"E Alborzi","year":"2023","unstructured":"Alborzi E, et al. Prevalence of human cytomegalovirus infection in Iranian prostate Cancer patients. Iran J Med Microbiol. 2023;17(4):379\u201386.","journal-title":"Iran J Med Microbiol"},{"issue":"1","key":"2682_CR85","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2217\/fvl-2019-0140","volume":"15","author":"SS Malekshahi","year":"2020","unstructured":"Malekshahi SS, et al. Epstein-Barr and BK virus in cancerous and noncancerous prostate tissue. Future Virol. 2020;15(1):13\u20137.","journal-title":"Future Virol"},{"issue":"20","key":"2682_CR86","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.3390\/cancers15204994","volume":"15","author":"F Bouezzedine","year":"2023","unstructured":"Bouezzedine F, et al. Polyploid giant cancer cells generated from human cytomegalovirus-infected prostate epithelial cells. Cancers. 2023;15(20):4994.","journal-title":"Cancers"},{"issue":"4","key":"2682_CR87","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/09564624221148622","volume":"34","author":"AP Amini","year":"2023","unstructured":"Amini AP, et al. The association between penile cancer and HIV infection: A literature review. Int J STD AIDS. 2023;34(4):214\u201328.","journal-title":"Int J STD AIDS"},{"issue":"5","key":"2682_CR88","doi-asserted-by":"publisher","first-page":"e0300729","DOI":"10.1371\/journal.pone.0300729","volume":"19","author":"C Mumba","year":"2024","unstructured":"Mumba C, et al. The effects of HIV and oncogenic human papillomavirus on the tumor immune microenvironment of penile squamous cell carcinoma. PLoS ONE. 2024;19(5):e0300729.","journal-title":"PLoS ONE"},{"issue":"10437","key":"2682_CR89","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"James ND, et al. The lancet commission on prostate cancer: planning for the surge in cases. Lancet. 2024;403(10437):1683\u2013722.","journal-title":"Lancet"},{"issue":"6","key":"2682_CR90","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","volume":"4","author":"G Gandaglia","year":"2021","unstructured":"Gandaglia G, et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4(6):877\u201392.","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"2682_CR91","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1128\/jcm.28.3.409-412.1990","volume":"28","author":"P McNicol","year":"1990","unstructured":"McNicol P, Dodd J. Detection of human papillomavirus DNA in prostate gland tissue by using the polymerase chain reaction amplification assay. J Clin Microbiol. 1990;28(3):409\u201312.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"2682_CR92","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.3892\/ol.2017.6367","volume":"14","author":"B Yin","year":"2017","unstructured":"Yin B, et al. Association between human papillomavirus and prostate cancer: A meta-analysis. Oncol Lett. 2017;14(2):1855\u201365.","journal-title":"Oncol Lett"},{"issue":"4","key":"2682_CR93","doi-asserted-by":"publisher","first-page":"152855","DOI":"10.1016\/j.prp.2020.152855","volume":"216","author":"S Mostafaei","year":"2020","unstructured":"Mostafaei S, et al. Viral infections and risk of thyroid cancer: a systematic review and empirical bayesian meta-analysis. Pathology-Research Pract. 2020;216(4):152855.","journal-title":"Pathology-Research Pract"},{"key":"2682_CR94","doi-asserted-by":"crossref","unstructured":"Yin S-H et al. Association of prostate cancer with human papillomavirus infections: A case-control study. Prostate Cancer Prostatic Dis. 2024;27(4):743\u2013748.","DOI":"10.1038\/s41391-023-00772-1"},{"issue":"1","key":"2682_CR95","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13027-022-00427-1","volume":"17","author":"JS Lawson","year":"2022","unstructured":"Lawson JS, Glenn WK. Multiple pathogens and prostate cancer. Infect Agents Cancer. 2022;17(1):23.","journal-title":"Infect Agents Cancer"},{"key":"2682_CR96","doi-asserted-by":"publisher","first-page":"106913","DOI":"10.1016\/j.intimp.2020.106913","volume":"88","author":"JS Nahand","year":"2020","unstructured":"Nahand JS, et al. The assessment of a possible link between HPV-mediated inflammation, apoptosis, and angiogenesis in prostate cancer. Int Immunopharmacol. 2020;88:106913.","journal-title":"Int Immunopharmacol"},{"key":"2682_CR97","doi-asserted-by":"publisher","first-page":"104576","DOI":"10.1016\/j.micpath.2020.104576","volume":"152","author":"M Fatemipour","year":"2021","unstructured":"Fatemipour M, et al. Human papillomavirus and prostate cancer: the role of viral expressed proteins in the Inhibition of Anoikis and induction of metastasis. Microb Pathog. 2021;152:104576.","journal-title":"Microb Pathog"},{"key":"2682_CR98","doi-asserted-by":"publisher","first-page":"105503","DOI":"10.1016\/j.micpath.2022.105503","volume":"166","author":"A Khatami","year":"2022","unstructured":"Khatami A, et al. Human papilloma virus (HPV) and prostate cancer (PCa): the potential role of HPV gene expression and selected cellular MiRNAs in PCa development. Microb Pathog. 2022;166:105503.","journal-title":"Microb Pathog"},{"issue":"1","key":"2682_CR99","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s40001-023-01207-2","volume":"28","author":"B Lang","year":"2023","unstructured":"Lang B, et al. Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients. Eur J Med Res. 2023;28(1):239.","journal-title":"Eur J Med Res"},{"key":"2682_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-08658-y","volume":"21","author":"JS Nahand","year":"2021","unstructured":"Nahand JS, et al. Possible role of HPV\/EBV coinfection in Anoikis resistance and development in prostate cancer. BMC Cancer. 2021;21:1\u201319.","journal-title":"BMC Cancer"},{"issue":"1","key":"2682_CR101","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1038\/s41598-023-34734-3","volume":"13","author":"MY Ahmed","year":"2023","unstructured":"Ahmed MY, et al. Detection of high-risk human papillomavirus in prostate cancer from a UK based population. Sci Rep. 2023;13(1):7633.","journal-title":"Sci Rep"},{"key":"2682_CR102","doi-asserted-by":"crossref","unstructured":"Baladehi RF, et al. The effect of oncogene proteins of human papillomaviruses on apoptosis pathways in prostate cancer. Volume 24. Oncologie (Tech Science; 2022. 2.","DOI":"10.32604\/oncologie.2022.020648"},{"issue":"15","key":"2682_CR103","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.3390\/cancers15153897","volume":"15","author":"R Opeyemi Bello","year":"2023","unstructured":"Opeyemi Bello R, et al. Does human papillomavirus play a causative role in prostate cancer?? A systematic review using Bradford Hill\u2019s criteria. Cancers. 2023;15(15):3897.","journal-title":"Cancers"},{"issue":"1","key":"2682_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00345-024-04949-8","volume":"42","author":"A W\u00e9ber","year":"2024","unstructured":"W\u00e9ber A, et al. Global burden of bladder cancer mortality in 2020 and 2040 according to GLOBOCAN estimates. World J Urol. 2024;42(1):1\u201310.","journal-title":"World J Urol"},{"key":"2682_CR105","doi-asserted-by":"crossref","unstructured":"Lopez-Beltran A et al. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024;12:384:e076743.","DOI":"10.1136\/bmj-2023-076743"},{"issue":"8","key":"2682_CR106","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/medicina57080749","volume":"57","author":"J Dobruch","year":"2021","unstructured":"Dobruch J, Oszczud\u0142owski M. Bladder cancer: current challenges and future directions. Medicina. 2021;57(8):749.","journal-title":"Medicina"},{"issue":"3","key":"2682_CR107","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.aju.2016.07.001","volume":"14","author":"JW Martin","year":"2016","unstructured":"Martin JW, et al. Squamous cell carcinoma of the urinary bladder: systematic review of clinical characteristics and therapeutic approaches. Arab J Urol. 2016;14(3):183\u201391.","journal-title":"Arab J Urol"},{"issue":"6","key":"2682_CR108","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0302-2838(03)00416-0","volume":"44","author":"P Dahm","year":"2003","unstructured":"Dahm P, Gschwend JE. Malignant non-urothelial neoplasms of the urinary bladder: a review. Eur Urol. 2003;44(6):672\u201381.","journal-title":"Eur Urol"},{"issue":"1","key":"2682_CR109","doi-asserted-by":"publisher","first-page":"e28208","DOI":"10.1002\/jmv.28208","volume":"95","author":"JX Sun","year":"2023","unstructured":"Sun JX, et al. The association between human papillomavirus and bladder cancer: evidence from meta-analysis and two\u2010sample Mendelian randomization. J Med Virol. 2023;95(1):e28208.","journal-title":"J Med Virol"},{"issue":"1","key":"2682_CR110","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/infdis\/jiaa710","volume":"224","author":"Y Yan","year":"2021","unstructured":"Yan Y, et al. Human papillomavirus prevalence and integration status in tissue samples of bladder cancer in the Chinese population. J Infect Dis. 2021;224(1):114\u201322.","journal-title":"J Infect Dis"},{"key":"2682_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13027-020-00318-3","volume":"15","author":"S Ohadian Moghadam","year":"2020","unstructured":"Ohadian Moghadam S, et al. Association of human papilloma virus (HPV) infection with oncological outcomes in urothelial bladder cancer. Infect Agents Cancer. 2020;15:1\u20138.","journal-title":"Infect Agents Cancer"},{"key":"2682_CR112","doi-asserted-by":"crossref","unstructured":"Pulatova AA, Clinical and morphological features of bladder cancer course in HPV-infected patients. \u042e\u0436\u043d\u043e-\u0440\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0436\u0443\u0440\u043d\u0430\u043b, 2023. 4(3 (eng)): pp. 12\u20139.","DOI":"10.37748\/2686-9039-2023-4-3-2"},{"issue":"9","key":"2682_CR113","doi-asserted-by":"publisher","first-page":"153084","DOI":"10.1016\/j.prp.2020.153084","volume":"216","author":"K Collins","year":"2020","unstructured":"Collins K, et al. Prevalence of high-risk human papillomavirus in primary squamous cell carcinoma of urinary bladder. Pathology-Research Pract. 2020;216(9):153084.","journal-title":"Pathology-Research Pract"},{"issue":"1\u20132","key":"2682_CR114","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000500467","volume":"104","author":"M Sarier","year":"2020","unstructured":"Sarier M, et al. Is there any association between urothelial carcinoma of the bladder and human papillomavirus? A case-control study. Urol Int. 2020;104(1\u20132):81\u20136.","journal-title":"Urol Int"},{"issue":"1","key":"2682_CR115","doi-asserted-by":"publisher","first-page":"140","DOI":"10.7150\/ijms.98334","volume":"22","author":"Z Tang","year":"2025","unstructured":"Tang Z, et al. HPV-Associated gene signatures in bladder cancer: A comprehensive prognostic model and its implications in immunotherapy. Int J Med Sci. 2025;22(1):140\u201357.","journal-title":"Int J Med Sci"},{"key":"2682_CR116","doi-asserted-by":"crossref","unstructured":"Ando T et al. Tumor-specific interendothelial adhesion mediated by FLRT2 facilitates cancer aggressiveness. J Clin Investig, 2022. 132(6).","DOI":"10.1172\/JCI153626"},{"issue":"5","key":"2682_CR117","doi-asserted-by":"publisher","first-page":"e17855","DOI":"10.1111\/jcmm.17855","volume":"28","author":"P Jiang","year":"2024","unstructured":"Jiang P, et al. FLRT2 suppresses bladder cancer progression through inducing ferroptosis. J Cell Mol Med. 2024;28(5):e17855.","journal-title":"J Cell Mol Med"},{"key":"2682_CR118","doi-asserted-by":"crossref","unstructured":"Ghelani G, et al. HPV-positive clinically advanced squamous cell carcinoma of the urinary bladder (aBSCC): A comprehensive genomic profiling (CGP) study. Urologic oncology: seminars and original investigations. 2023;41(12):486.e15\u2013486.e23.","DOI":"10.1016\/j.urolonc.2023.09.001"},{"key":"2682_CR119","doi-asserted-by":"publisher","first-page":"100202","DOI":"10.1016\/j.pvr.2020.100202","volume":"10","author":"DG Ferris","year":"2020","unstructured":"Ferris DG, et al. Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial. Papillomavirus Res. 2020;10:100202.","journal-title":"Papillomavirus Res"},{"key":"2682_CR120","doi-asserted-by":"crossref","unstructured":"Aqerrout M et al. Human papillomavirus as a potential etiological factor and biomarker in bladder carcinogenesis: A molecular epidemiological study. Gene Rep, 2024:102104.Volume 38","DOI":"10.1016\/j.genrep.2024.102104"},{"issue":"1","key":"2682_CR121","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12301-024-00414-5","volume":"30","author":"DS Dolgasheva","year":"2024","unstructured":"Dolgasheva DS, et al. Human papillomavirus and bladder cancer: literature review and meta-analysis. Afr J Urol. 2024;30(1):11.","journal-title":"Afr J Urol"},{"issue":"5","key":"2682_CR122","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/ijc.33999","volume":"151","author":"A Znaor","year":"2022","unstructured":"Znaor A, et al. Global patterns in testicular cancer incidence and mortality in 2020. Int J Cancer. 2022;151(5):692\u20138.","journal-title":"Int J Cancer"},{"issue":"4","key":"2682_CR123","first-page":"261","volume":"97","author":"DC Baird","year":"2018","unstructured":"Baird DC, Meyers GJ, Hu JS. Testicular cancer: diagnosis and treatment. Am Family Phys. 2018;97(4):261\u20138.","journal-title":"Am Family Phys"},{"issue":"7","key":"2682_CR124","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3390\/cancers11070984","volume":"11","author":"G Al-Khadairi","year":"2019","unstructured":"Al-Khadairi G, Decock J. Cancer testis antigens and immunotherapy: where do we stand in the targeting of PRAME? Cancers. 2019;11(7):984.","journal-title":"Cancers"},{"key":"2682_CR125","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s13402-017-0333-9","volume":"40","author":"T van Agthoven","year":"2017","unstructured":"van Agthoven T, Eijkenboom WM, Looijenga LH. microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients. Cell Oncol. 2017;40:379\u201388.","journal-title":"Cell Oncol"},{"issue":"8","key":"2682_CR126","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","volume":"11","author":"S Marur","year":"2010","unstructured":"Marur S, et al. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11(8):781\u20139.","journal-title":"Lancet Oncol"},{"issue":"3","key":"2682_CR127","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"key":"2682_CR128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-6169-0","volume":"20","author":"Y Li","year":"2020","unstructured":"Li Y, et al. Racial differences in testicular cancer in the united States: descriptive epidemiology. BMC Cancer. 2020;20:1\u201310.","journal-title":"BMC Cancer"},{"issue":"4","key":"2682_CR129","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.eururo.2009.06.006","volume":"57","author":"S Cummins","year":"2010","unstructured":"Cummins S, et al. Surveillance in stage I seminoma patients: a long-term assessment. Eur Urol. 2010;57(4):673\u20138.","journal-title":"Eur Urol"},{"key":"2682_CR130","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fendo.2012.00172","volume":"3","author":"A Garolla","year":"2012","unstructured":"Garolla A, et al. Testicular cancer and HPV semen infection. Front Endocrinol. 2012;3:172.","journal-title":"Front Endocrinol"},{"issue":"1","key":"2682_CR131","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jmv.23431","volume":"85","author":"G Bertazzoni","year":"2013","unstructured":"Bertazzoni G, et al. Lack of evidence for an association between seminoma and human papillomavirus infection using GP5+\/GP6\u2009+\u2009consensus primers. J Med Virol. 2013;85(1):105\u20139.","journal-title":"J Med Virol"},{"key":"2682_CR132","doi-asserted-by":"crossref","unstructured":"Siegel RL et al. Cancer statistics, 2021. CA: a cancer journal for clinicians. 2021;71(1):7\u201333.","DOI":"10.3322\/caac.21654"},{"key":"2682_CR133","doi-asserted-by":"crossref","unstructured":"Giona S. The epidemiology of penile cancer. Urologic Cancers [Internet]; 2022.","DOI":"10.36255\/exon-publications-urologic-cancers-epidemiology-penile-cancer"},{"issue":"1","key":"2682_CR134","first-page":"91","volume":"20","author":"L Iorga","year":"2020","unstructured":"Iorga L, et al. Penile carcinoma and HPV infection. Experimental Therapeutic Med. 2020;20(1):91\u20136.","journal-title":"Experimental Therapeutic Med"},{"issue":"10","key":"2682_CR135","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/S1473-3099(20)30687-3","volume":"21","author":"EP Chow","year":"2021","unstructured":"Chow EP, et al. Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study. Lancet Infect Dis. 2021;21(10):1448\u201357.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2682_CR136","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.euo.2023.10.013","volume":"7","author":"CA Moen","year":"2024","unstructured":"Moen CA, et al. Penile cancers attributed to human papillomavirus are associated with improved survival for node-positive patients. Findings from a Norwegian cohort study spanning 50 years. Eur Urol Oncol. 2024;7(4):778\u201385.","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"2682_CR137","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1470-2045(18)30682-X","volume":"20","author":"TB Olesen","year":"2019","unstructured":"Olesen TB, et al. Prevalence of human papillomavirus DNA and p16INK4a in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis. Lancet Oncol. 2019;20(1):145\u201358.","journal-title":"Lancet Oncol"},{"key":"2682_CR138","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3389\/fonc.2020.01521","volume":"10","author":"W Gu","year":"2020","unstructured":"Gu W, et al. Importance of HPV in Chinese penile cancer: a contemporary multicenter study. Front Oncol. 2020;10:1521.","journal-title":"Front Oncol"},{"issue":"4","key":"2682_CR139","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/path.5475","volume":"251","author":"B Medeiros-Fonseca","year":"2020","unstructured":"Medeiros-Fonseca B, et al. HPV16 induces penile intraepithelial neoplasia and squamous cell carcinoma in Transgenic mice: first mouse model for HPV\u2010related penile cancer. J Pathol. 2020;251(4):411\u20139.","journal-title":"J Pathol"},{"issue":"4","key":"2682_CR140","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/bju.15221","volume":"127","author":"S Kristiansen","year":"2021","unstructured":"Kristiansen S, et al. Penile intraepithelial neoplasia, penile cancer precursors and human papillomavirus prevalence in symptomatic preputium: a cross-sectional study of 351 circumcised men in Sweden. BJU Int. 2021;127(4):428\u201334.","journal-title":"BJU Int"},{"issue":"1","key":"2682_CR141","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1186\/s12885-022-10127-z","volume":"22","author":"AAL Teixeira J\u00fanior","year":"2022","unstructured":"Teixeira J\u00fanior AAL, et al. A comprehensive analysis of penile cancer in the region with the highest worldwide incidence reveals new insights into the disease. BMC Cancer. 2022;22(1):1063.","journal-title":"BMC Cancer"},{"key":"2682_CR142","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.humpath.2019.09.013","volume":"96","author":"M-L Eich","year":"2020","unstructured":"Eich M-L, et al. Morphology, p16, HPV, and outcomes in squamous cell carcinoma of the penis: a multi-institutional study. Hum Pathol. 2020;96:79\u201386.","journal-title":"Hum Pathol"},{"issue":"5","key":"2682_CR143","doi-asserted-by":"publisher","first-page":"791","DOI":"10.21037\/tau.2017.06.27","volume":"6","author":"LC Kidd","year":"2017","unstructured":"Kidd LC, et al. Relationship between human papillomavirus and penile cancer\u2014implications for prevention and treatment. Translational Androl Urol. 2017;6(5):791.","journal-title":"Translational Androl Urol"},{"key":"2682_CR144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11864-020-00802-3","volume":"22","author":"ME Ahmed","year":"2021","unstructured":"Ahmed ME, et al. Progress on management of penile cancer in 2020. Curr Treat Options Oncol. 2021;22:1\u201313.","journal-title":"Curr Treat Options Oncol"},{"key":"2682_CR145","doi-asserted-by":"publisher","first-page":"1463445","DOI":"10.3389\/fonc.2024.1463445","volume":"14","author":"SJA Guimar\u00e3es","year":"2024","unstructured":"Guimar\u00e3es SJA, et al. Human papillomavirus infection affects the immune microenvironment and antigen presentation in penile cancer. Front Oncol. 2024;14:1463445.","journal-title":"Front Oncol"},{"issue":"9","key":"2682_CR146","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/bjc.2017.74","volume":"116","author":"N Guimer\u00e0","year":"2017","unstructured":"Guimer\u00e0 N, et al. Human papillomavirus 16 is an aetiological factor of scrotal cancer. Br J Cancer. 2017;116(9):1218\u201322.","journal-title":"Br J Cancer"},{"issue":"10","key":"2682_CR147","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1158\/1055-9965.EPI-18-0322","volume":"27","author":"FL Sand","year":"2018","unstructured":"Sand FL, et al. Prognostic significance of HPV and p16 status in men diagnosed with penile cancer: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2018;27(10):1123\u201332.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"14","key":"2682_CR148","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.3390\/cancers15143713","volume":"15","author":"K Parza","year":"2023","unstructured":"Parza K, et al. The prognostic role of human papillomavirus and p16 status in penile squamous cell carcinoma\u2014a systematic review. Cancers. 2023;15(14):3713.","journal-title":"Cancers"},{"issue":"23","key":"2682_CR149","doi-asserted-by":"publisher","first-page":"16808","DOI":"10.3390\/ijms242316808","volume":"24","author":"L Wei","year":"2023","unstructured":"Wei L, et al. Human papillomavirus infection in penile cancer: multidimensional mechanisms and vaccine strategies. Int J Mol Sci. 2023;24(23):16808.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2682_CR150","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/ndt\/gfae036","volume":"39","author":"L Cirillo","year":"2024","unstructured":"Cirillo L, Innocenti S, Becherucci F. Global epidemiology of kidney cancer. Nephrol Dialysis Transplantation. 2024;39(6):920\u20138.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"5","key":"2682_CR151","doi-asserted-by":"publisher","first-page":"785","DOI":"10.21037\/tau.2017.05.19","volume":"6","author":"A Douglawi","year":"2017","unstructured":"Douglawi A, Masterson TA. Updates on the epidemiology and risk factors for penile cancer. Translational Androl Urol. 2017;6(5):785.","journal-title":"Translational Androl Urol"},{"issue":"6","key":"2682_CR152","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.eururo.2023.02.027","volume":"83","author":"OR Brouwer","year":"2023","unstructured":"Brouwer OR, et al. European association of Urology-American society of clinical oncology collaborative guideline on penile cancer: 2023 update. Eur Urol. 2023;83(6):548\u201360.","journal-title":"Eur Urol"},{"issue":"5","key":"2682_CR153","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","volume":"82","author":"H Moch","year":"2022","unstructured":"Moch H, et al. The 2022 world health organization classification of tumours of the urinary system and male genital organs\u2014part A: renal, penile, and testicular tumours. Eur Urol. 2022;82(5):458\u201368.","journal-title":"Eur Urol"},{"issue":"7","key":"2682_CR154","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/jmv.23945","volume":"86","author":"A Farhadi","year":"2014","unstructured":"Farhadi A, et al. High-risk human papillomavirus infection in different histological subtypes of renal cell carcinoma. J Med Virol. 2014;86(7):1134\u201344.","journal-title":"J Med Virol"},{"key":"2682_CR155","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.humpath.2015.09.021","volume":"48","author":"L Yan","year":"2016","unstructured":"Yan L, et al. Polyomavirus large T antigen is prevalent in urothelial carcinoma post\u2013kidney transplant. Hum Pathol. 2016;48:122\u201331.","journal-title":"Hum Pathol"},{"issue":"2","key":"2682_CR156","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.canlet.2014.11.008","volume":"356","author":"S Dogra","year":"2015","unstructured":"Dogra S, et al. Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6\/E7 for further therapeutic directions in renal cell carcinoma. Cancer Lett. 2015;356(2):953\u201361.","journal-title":"Cancer Lett"},{"issue":"1","key":"2682_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5527\/wjn.v11.i1.1","volume":"11","author":"M Bersanelli","year":"2022","unstructured":"Bersanelli M, et al. Renal cell carcinoma and viral infections: A dangerous relationship? World J Nephrol. 2022;11(1):1.","journal-title":"World J Nephrol"},{"issue":"1","key":"2682_CR158","first-page":"53","volume":"23","author":"M Salehipoor","year":"2012","unstructured":"Salehipoor M, et al. Role of viruses in renal cell carcinoma. Saudi J Kidney Dis Transplantation. 2012;23(1):53\u20137.","journal-title":"Saudi J Kidney Dis Transplantation"},{"key":"2682_CR159","doi-asserted-by":"publisher","first-page":"1367720","DOI":"10.3389\/fruro.2024.1367720","volume":"4","author":"G Randazzo","year":"2024","unstructured":"Randazzo G, et al. Urinary Microbiome and urological cancers: a Mini review. Front Urol. 2024;4:1367720.","journal-title":"Front Urol"},{"issue":"11","key":"2682_CR160","doi-asserted-by":"publisher","first-page":"6909","DOI":"10.3390\/curroncol31110511","volume":"31","author":"RM Antar","year":"2024","unstructured":"Antar RM, et al. The evolving molecular landscape and actionable alterations in urologic cancers. Curr Oncol. 2024;31(11):6909\u201337.","journal-title":"Curr Oncol"},{"issue":"1","key":"2682_CR161","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12935-023-02861-6","volume":"23","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, et al. A review on the role of long non-coding RNA and MicroRNA network in clear cell renal cell carcinoma and its tumor microenvironment. Cancer Cell Int. 2023;23(1):16.","journal-title":"Cancer Cell Int"},{"key":"2682_CR162","first-page":"316","volume":"297","author":"F El Battioui","year":"2023","unstructured":"El Battioui F, et al. Progress in the development of vaccines against human papillomavirus. Oncogenic Viruses. 2023;297:316.","journal-title":"Oncogenic Viruses"},{"issue":"12","key":"2682_CR163","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3390\/cells8121637","volume":"8","author":"J Lobo","year":"2019","unstructured":"Lobo J, et al. Identification and validation model for informative liquid biopsy-based MicroRNA biomarkers: insights from germ cell tumor in vitro, in vivo and patient-derived data. Cells. 2019;8(12):1637.","journal-title":"Cells"},{"issue":"2","key":"2682_CR164","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/bib\/bbw114","volume":"19","author":"C Manzoni","year":"2018","unstructured":"Manzoni C, et al. Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences. Brief Bioinform. 2018;19(2):286\u2013302.","journal-title":"Brief Bioinform"},{"issue":"4","key":"2682_CR165","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.clgc.2015.12.019","volume":"14","author":"K Zargar-Shoshtari","year":"2016","unstructured":"Zargar-Shoshtari K, et al. Clinical significance of p53 and p16ink4a status in a contemporary North American penile carcinoma cohort. Clin Genitourin Cancer. 2016;14(4):346\u201351.","journal-title":"Clin Genitourin Cancer"},{"issue":"10031","key":"2682_CR166","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","volume":"387","author":"JE Rosenberg","year":"2016","unstructured":"Rosenberg JE, et al. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Lancet. 2016;387(10031):1909\u201320.","journal-title":"Lancet"},{"issue":"10","key":"2682_CR167","doi-asserted-by":"publisher","first-page":"100250","DOI":"10.1016\/j.modpat.2023.100250","volume":"36","author":"MS Ermakov","year":"2023","unstructured":"Ermakov MS, Kashofer K, Regauer S. Different mutational landscapes in human Papillomavirus\u2013Induced and human Papillomavirus\u2013Independent invasive penile squamous cell cancers. Mod Pathol. 2023;36(10):100250.","journal-title":"Mod Pathol"},{"issue":"9","key":"2682_CR168","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3390\/pathogens13090809","volume":"13","author":"G Mannam","year":"2024","unstructured":"Mannam G, et al. HPV and penile cancer: epidemiology, risk factors, and clinical insights. Pathogens. 2024;13(9):809.","journal-title":"Pathogens"},{"issue":"3 Part 1","key":"2682_CR169","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.juro.2016.09.088","volume":"197","author":"SR Ottenhof","year":"2017","unstructured":"Ottenhof SR, et al. Expression of programmed death ligand 1 in penile cancer is of prognostic value and associated with HPV status. J Urol. 2017;197(3 Part 1):690\u20137.","journal-title":"J Urol"},{"issue":"3","key":"2682_CR170","doi-asserted-by":"publisher","first-page":"e17517","DOI":"10.1371\/journal.pone.0017517","volume":"6","author":"E Stankiewicz","year":"2011","unstructured":"Stankiewicz E, et al. Alternative HER\/PTEN\/Akt pathway activation in HPV positive and negative penile carcinomas. PLoS ONE. 2011;6(3):e17517.","journal-title":"PLoS ONE"},{"key":"2682_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-015-0082-4","volume":"7","author":"H Kuasne","year":"2015","unstructured":"Kuasne H, et al. Genome-wide methylation and transcriptome analysis in penile carcinoma: Uncovering new molecular markers. Clin Epigenetics. 2015;7:1\u201310.","journal-title":"Clin Epigenetics"},{"key":"2682_CR172","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.humpath.2016.10.019","volume":"61","author":"E Peta","year":"2017","unstructured":"Peta E, et al. Down-regulation of microRNA-146a is associated with high-risk human papillomavirus infection and epidermal growth factor receptor overexpression in penile squamous cell carcinoma. Hum Pathol. 2017;61:33\u201340.","journal-title":"Hum Pathol"},{"issue":"9","key":"2682_CR173","doi-asserted-by":"publisher","first-page":"15294","DOI":"10.18632\/oncotarget.14783","volume":"8","author":"H Kuasne","year":"2017","unstructured":"Kuasne H, et al. Integrative MiRNA and mRNA analysis in penile carcinomas reveals markers and pathways with potential clinical impact. Oncotarget. 2017;8(9):15294.","journal-title":"Oncotarget"},{"issue":"5","key":"2682_CR174","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1056\/NEJMoa0909537","volume":"364","author":"AR Giuliano","year":"2011","unstructured":"Giuliano AR, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med. 2011;364(5):401\u201311.","journal-title":"N Engl J Med"},{"key":"2682_CR175","doi-asserted-by":"crossref","unstructured":"Elst L, Albersen M. HPV vaccination: does it have a role in preventing penile cancer and other preneoplastic lesions? Seminars Oncol Nurs. 2022;38(3):151284.","DOI":"10.1016\/j.soncn.2022.151284"},{"key":"2682_CR176","doi-asserted-by":"crossref","unstructured":"Maldonado I, et al. Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27\u201345 years. Volume 18. Human Vaccines & Immunotherapeutics; 2022. p. 2078626. 5.","DOI":"10.1080\/21645515.2022.2078626"},{"issue":"2","key":"2682_CR177","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40618-023-02192-3","volume":"47","author":"A Garolla","year":"2024","unstructured":"Garolla A, et al. HPV-related diseases in male patients: an underestimated conundrum. J Endocrinol Investig. 2024;47(2):261\u201374.","journal-title":"J Endocrinol Investig"},{"issue":"6","key":"2682_CR178","doi-asserted-by":"publisher","first-page":"e0198615","DOI":"10.1371\/journal.pone.0198615","volume":"13","author":"T Cheung","year":"2018","unstructured":"Cheung T, et al. Acceptability of HPV vaccines and associations with perceptions related to HPV and HPV vaccines among male baccalaureate students in Hong Kong. PLoS ONE. 2018;13(6):e0198615.","journal-title":"PLoS ONE"},{"issue":"4","key":"2682_CR179","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/ajcp\/aqz186","volume":"153","author":"M Cao","year":"2020","unstructured":"Cao M, et al. Increased high-risk human papillomavirus viral load is associated with immunosuppressed microenvironment and predicts a worse long-term survival in cervical cancer patients. Am J Clin Pathol. 2020;153(4):502\u201312.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2682_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jiph.2018.06.005","volume":"12","author":"J Krzowska-Firych","year":"2019","unstructured":"Krzowska-Firych J, et al. An overview of human papillomavirus (HPV) as an etiological factor of the anal cancer. J Infect Public Health. 2019;12(1):1\u20136.","journal-title":"J Infect Public Health"},{"issue":"2","key":"2682_CR181","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1080\/13685538.2018.1455178","volume":"23","author":"GI Russo","year":"2020","unstructured":"Russo GI, et al. Human papillomavirus and risk of prostate cancer: a systematic review and meta-analysis. Aging Male. 2020;23(2):132\u20138.","journal-title":"Aging Male"},{"key":"2682_CR182","first-page":"65","volume":"35","author":"M Soheili","year":"2021","unstructured":"Soheili M, et al. Human papilloma virus: A review study of epidemiology, carcinogenesis, diagnostic methods, and treatment of all HPV-related cancers. Med J Islamic Repub Iran. 2021;35:65.","journal-title":"Med J Islamic Repub Iran"},{"issue":"10","key":"2682_CR183","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3390\/vaccines9101069","volume":"9","author":"W He","year":"2021","unstructured":"He W, et al. Analysis of HPV vaccination willingness amongst HIV-negative men who have sex with men in China. Vaccines. 2021;9(10):1069.","journal-title":"Vaccines"},{"key":"2682_CR184","doi-asserted-by":"crossref","unstructured":"Pan H, et al. Factors influencing HPV vaccination willingness among men who have sex with men in China: A structural equation modeling analysis. Volume 18. Human vaccines & immunotherapeutics; 2022. p. 2038504. 1.","DOI":"10.1080\/21645515.2022.2038504"},{"issue":"2","key":"2682_CR185","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.currproblcancer.2018.03.003","volume":"42","author":"S Gupta","year":"2018","unstructured":"Gupta S, Kumar P, Das BC. Molecular pathways and targets. Curr Probl Cancer. 2018;42(2):161\u201374.","journal-title":"Curr Probl Cancer"},{"key":"2682_CR186","doi-asserted-by":"crossref","unstructured":"Aggarwal S, Agarwal P, Gupta N. A comprehensive narrative review of challenges and facilitators in the implementation of various HPV vaccination program worldwide. Cancer Med, 2024.Volume 13","DOI":"10.1002\/cam4.6862"},{"key":"2682_CR187","unstructured":"Ghebreyesus, T., WHO Director-General calls for all countries to take action to help end the suffering caused by cervical cancer. 2018, Geneva: WHO, 2018. https:\/\/www.who.int\/reproductivehealth\/call-to-action."},{"key":"2682_CR188","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s11864-014-0309-1","volume":"15","author":"NG Chau","year":"2014","unstructured":"Chau NG, Rabinowits G, Haddad RI. Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment options. Curr Treat Options Oncol. 2014;15:595\u2013610.","journal-title":"Curr Treat Options Oncol"},{"issue":"13","key":"2682_CR189","doi-asserted-by":"publisher","first-page":"10846","DOI":"10.3390\/ijms241310846","volume":"24","author":"A Aveta","year":"2023","unstructured":"Aveta A, et al. Urinary MicroRNAs as biomarkers of urological cancers: a systematic review. Int J Mol Sci. 2023;24(13):10846.","journal-title":"Int J Mol Sci"},{"key":"2682_CR190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-019-1086-5","volume":"20","author":"MH Pourhanifeh","year":"2020","unstructured":"Pourhanifeh MH, et al. Melatonin and urological cancers: A new therapeutic approach. Cancer Cell Int. 2020;20:1\u201311.","journal-title":"Cancer Cell Int"},{"issue":"4","key":"2682_CR191","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.eururo.2022.01.028","volume":"81","author":"Z Wu","year":"2022","unstructured":"Wu Z, et al. Adverse events of immune checkpoint inhibitors therapy for urologic cancer patients in clinical trials: a collaborative systematic review and meta-analysis. Eur Urol. 2022;81(4):414\u201325.","journal-title":"Eur Urol"},{"issue":"2","key":"2682_CR192","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1128\/CVI.05208-11","volume":"19","author":"RJ Hillman","year":"2012","unstructured":"Hillman RJ, et al. Immunogenicity of the quadrivalent human papillomavirus (type 6\/11\/16\/18) vaccine in males 16 to 26 years old. Clin Vaccine Immunol. 2012;19(2):261\u20137.","journal-title":"Clin Vaccine Immunol"},{"issue":"11","key":"2682_CR193","first-page":"300","volume":"64","author":"E Petrosky","year":"2015","unstructured":"Petrosky E, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64(11):300\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2682_CR194","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-015-1598-x","volume":"15","author":"W Owadally","year":"2015","unstructured":"Owadally W, et al. PATHOS: a phase II\/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV) positive oropharyngeal cancer. BMC Cancer. 2015;15:1\u201310.","journal-title":"BMC Cancer"},{"key":"2682_CR195","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.rvsc.2020.08.008","volume":"133","author":"V Podarala","year":"2020","unstructured":"Podarala V, et al. Efficacy of BCG vaccine and mitomycin C for the treatment of ocular squamous cell carcinoma in bovines. Res Vet Sci. 2020;133:48\u201352.","journal-title":"Res Vet Sci"},{"issue":"2","key":"2682_CR196","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41416-020-01108-9","volume":"124","author":"G Zheng","year":"2021","unstructured":"Zheng G, et al. Association of post-diagnostic use of cholera vaccine with survival outcome in breast cancer patients. Br J Cancer. 2021;124(2):506\u201312.","journal-title":"Br J Cancer"},{"issue":"3","key":"2682_CR197","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/vaccines8030473","volume":"8","author":"M Tognon","year":"2020","unstructured":"Tognon M, et al. Investigation on spontaneous abortion and human papillomavirus infection. Vaccines. 2020;8(3):473.","journal-title":"Vaccines"},{"issue":"16","key":"2682_CR198","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1002\/cam4.4091","volume":"10","author":"FY Musangile","year":"2021","unstructured":"Musangile FY, et al. Detection of HPV infection in urothelial carcinoma using RNAscope: clinicopathological characterization. Cancer Med. 2021;10(16):5534\u201344.","journal-title":"Cancer Med"},{"issue":"10","key":"2682_CR199","first-page":"232","volume":"10","author":"H Badawi","year":"2008","unstructured":"Badawi H, et al. Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients. Medscape J Med. 2008;10(10):232.","journal-title":"Medscape J Med"},{"key":"2682_CR200","doi-asserted-by":"crossref","unstructured":"Tolstov Y, et al. Human papillomaviruses In urological malignancies: a critical assessment. In urologic oncology: seminars and original investigations. Elsevier; 2014.","DOI":"10.1016\/j.urolonc.2013.06.012"},{"issue":"19","key":"2682_CR201","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.vaccine.2013.03.006","volume":"31","author":"J Horn","year":"2013","unstructured":"Horn J, et al. Estimating the long-term effects of HPV vaccination in Germany. Vaccine. 2013;31(19):2372\u201380.","journal-title":"Vaccine"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02682-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02682-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02682-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T19:04:10Z","timestamp":1740769450000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02682-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":201,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2682"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02682-1","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"22 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}